Smith J. Jefferson, an officer at Precision BioSciences, Inc., has filed a notice to sell 875 shares of the company's common stock. This transaction, valued at approximately $8,955.85, was reported in a recent SEC filing dated November 6, 2026. Such moves can signal changes in ownership dynamics and may impact investor sentiment.

Background

Precision BioSciences, Inc., incorporated in Delaware, operates in the biological products sector. The company is listed under the SEC file number 001-38841. Its business address is 302 East Pettigrew Street, Suite A-100, Durham, NC 27701. The firm focuses on developing innovative therapies and products in the life sciences field.

What the Filing Says

The filing indicates that Smith J. Jefferson sold 875 shares of Precision BioSciences, with an aggregate market value of $8,955.85. The shares were sold on November 6, 2026, and were acquired as founders' shares back in 2006. The filing also noted that there were no securities sold in the past three months, except for a previous sale by James J. Smith, who is identified as the same individual as J. Jefferson Smith.

Impact

This transaction may affect various stakeholders, including other shareholders, company executives, and market analysts. Observers in the biological products industry may view this as a reflection of market conditions and internal company dynamics.

What's Next

The filing does not say what happens next.